acute coronary syndrome

Advertisement
Patrick DalyAtrial Fibrillation | July 10, 2025
Antithrombotic therapy with oral anticoagulants (OACs) was associated with reduced risk of ischemic events without ...
DocWire News EditorsAtrial Fibrillation | July 10, 2025
A team of researchers, led by Jean Jacques Noubiap, aimed to evaluate the incidence, risk factors, and prognosis of ...
DocWire News EditorsAtherosclerotic Disease | July 10, 2025
A new high-sensitivity cardiac troponin helps predict adverse cardiovascular events in diabetic patients with critical ...
DocWire News EditorsTCT 2020 | July 10, 2025
The use of fractional flow reserve (FFR) combined with optical coherence tomography (OCT) improves the accuracy of ...
DocWire News EditorsInterventional Cardiology | July 10, 2025
In patients with a coronary artery bypass graft (CABG) procedure prior to an acute coronary syndrome, alirocumab added ...
Kaitlyn D’OnofrioOncology | September 22, 2023
Roche’s Rozlytrek (entrectinib) has been priced at about half the cost of its competitor, Vitrakvi (larotrectinib), ...
Rob DillardCardiology | July 10, 2025
There exists a link between cancer and takotsubo syndrome (TTS) also known as broken heart syndrome, according to a ...
DocWire News EditorsCardiology | July 10, 2025
This week's edition features a look at research on the IMPROVE-IT population and a potential benefit for elderly ...
DocWire News EditorsCardiology | July 10, 2025
A new analysis suggests that elderly patients may benefit from a high-intensity simvastatin-ezetimibe combination after ...
DocWire News EditorsCardiology | July 10, 2025
This week's edition has some news for those who take nutritional supplements to prevent cardiovascular outcomes, a vote ...
DocWire News EditorsLipid Management | July 10, 2025
A recent analysis of the results of the ODYSSEY OUTCOMES trail suggests that the PCSK9 inhibitor alirocumab added to ...
DocWire News EditorsInterventional Cardiology | June 5, 2019
The digitally supported self-management and self-detection of symptom onset for coronary artery occlusion is feasible, ...
DocWire News EditorsACC 2019 Conference | July 10, 2025
The combination of apixaban and clopidogrel was associated with a reduced risk for bleeding and hospitalization in ...
DocWire News EditorsACC 2019 Conference | March 16, 2019
Depression screening in survivors of acute coronary syndromes (ACS) had no impact on quality of life, according to study ...
DocWire News EditorsCardiology | July 10, 2025
Patients on the extreme end of the coronary artery disease spectrum, like those with recurring acute coronary syndrome ...
DocWire News EditorsCardiology | July 10, 2025
High-sensitivity C-reactive protein (hsCRP) levels were associated with increased risk for suffering averse cardiac ...
DocWire News EditorsLipid Management | July 10, 2025
The cholesterol-lowering PCSK9 inhibitor alirocumab reduced the risk for a second heart in patients who had survived ...
DocWire News EditorsTCT 2018 | September 24, 2018
A polymer-coated zotarolimus-eluting stent (Resolute Onyx) with a novel thin-strut metallic platform demonstrated ...
DocWire News EditorsLipid Management | July 10, 2025
The high-density lipoprotein (HDL) mimetic MDCO-216 does not cause plaque regression in statin-treated acute ...
DocWire News EditorsACC 2018 Conference | July 10, 2025
Patients younger than 75 years of age who suffered an MI and were given ticagrelor did not see an increased risk for ...
Advertisement